SCHEMBL4931071

SCHEMBL4931071

CC1(C)[C@H]2CC[C@H](C2)[C@H]1O

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
TSHR P16473 2/20 0.32
KDM4E B2RXH2 1/20 0.32
HTT P42858 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
MAPK1 P28482 1/20 0.31
CHRNB2 P17787 4/20 0.30
CHRNB4 P30926 4/20 0.30
CHRNA3 P32297 4/20 0.30
CHRNA7 P36544 4/20 0.30
CHRNA4 P43681 4/20 0.30
CHRNA1 P02708 3/20 0.30
CHRNG P07510 3/20 0.30
CHRNB1 P11230 3/20 0.30
CHRND Q07001 3/20 0.30
LMNA P02545 1/20 0.30
CYP3A4 P08684 1/20 0.30
PKM P14618 1/20 0.30
NFKB1 P19838 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6899186 1.00 ALDH1A1 (0.37) ALDH1A1NPSR1TSHRKDM4EHTT
SCHEMBL14721823 1.00 ALDH1A1 (0.37) ALDH1A1NPSR1TSHRKDM4EHTT
SCHEMBL24477676 1.00 ALDH1A1 (0.37) ALDH1A1NPSR1TSHRKDM4EHTT
SCHEMBL10582187 0.78
Methyl Alcohol SCHEMBL4652953 0.73 ALDH1A1 (0.36) ALDH1A1NPSR1
SCHEMBL215249 0.72 ALDH1A1 (0.34) ALDH1A1NPSR1CHRNB2CHRNB4CHRNA3
SCHEMBL1496206 0.72 ALDH1A1 (0.34) ALDH1A1NPSR1CHRNB2CHRNB4CHRNA3
SCHEMBL7428255 0.70 ALDH1A1 (0.37) ALDH1A1NPSR1CHRNB2CHRNB4CHRNA3
SCHEMBL14393370 0.70 ALDH1A1 (0.37) ALDH1A1NPSR1CHRNB2CHRNB4CHRNA3
SCHEMBL24586087 0.70 ALDH1A1 (0.37) ALDH1A1NPSR1CHRNB2CHRNB4CHRNA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080249077-A1 17.Beta.-Fluoromethoxycarbonyl-Androst-4-En-3-One Compounds With a 17.Alpha.-Carbonate Sustituent GLAXO GROUP LIMITED (GB) 2008-10-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080249077-A1 17.Beta.-Fluoromethoxycarbonyl-Androst-4-En-3-One Compounds With a 17.Alpha.-Carbonate Sustituent HSD17B7, CYP17A1, HSD3B1 ALDH1A1 435/4885NPSR1 876/4885TSHR 1005/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.